Some possibility of the SPP additional supply hitting market...

Some possibility of the SPP additional supply hitting market next Tues.
Its a question of how many who took part to add to long, and how many to flip.
And how many already have flipped, and rely on the SPP allocation to replace their long scrip already sold.
Assume that they would only do so, and to do so, when above the 10c obviously.
Also, if the SPP is scaled back, rookie mistake, could leave some early flippers short on long position and need to buy on market.

Point is, be mindful of the last of this washing out next week. Beyond then, everyone should be looking forward to progressing towards 2024 commercial news events.

If we look a couple of years ahead, with the assumption that this is all regulatory approvals in place to roll down the runway, then take a slice of $350 per test, how much in house / what is the profit margin to share holders ? Vs profit margin if outsourced ? But whatever those rates are, multiply by X million blood tests, modest PE ratio and theres your path to a unicorn. = $1b valuation = $4-5 per share. Then if it gets volumes overseas, well, many many unicorns. And people get a gambling hand today for 10c.

14 years in the making, and a year or so to go. Bring on the FOMO. And bet (gamble) on us getting our patent granted, and all other green lights on the regulatory runway.